Logo image of APLT

APPLIED THERAPEUTICS INC (APLT) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:APLT - US03828A1016 - Common Stock

0.125 USD
+0 (+1.13%)
Last: 12/19/2025, 8:00:00 PM
0.1262 USD
+0 (+0.96%)
After Hours: 12/19/2025, 8:00:00 PM
Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to APLT. APLT was compared to 530 industry peers in the Biotechnology industry. Both the profitability and financial health of APLT have multiple concerns. APLT does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

APLT had negative earnings in the past year.
APLT had a negative operating cash flow in the past year.
APLT had negative earnings in each of the past 5 years.
APLT had a negative operating cash flow in each of the past 5 years.
APLT Yearly Net Income VS EBIT VS OCF VS FCFAPLT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 -20M -40M -60M -80M -100M

1.2 Ratios

Looking at the Return On Assets, with a value of -52.77%, APLT is in line with its industry, outperforming 46.99% of the companies in the same industry.
Industry RankSector Rank
ROA -52.77%
ROE N/A
ROIC N/A
ROA(3y)-185.04%
ROA(5y)-152.5%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
APLT Yearly ROA, ROE, ROICAPLT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 -1K -1.5K -2K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for APLT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
APLT Yearly Profit, Operating, Gross MarginsAPLT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 -5K -10K -15K -20K

More info and screens

0

2. Health

2.1 Basic Checks

APLT does not have a ROIC to compare to the WACC, probably because it is not profitable.
APLT has more shares outstanding than it did 1 year ago.
APLT has more shares outstanding than it did 5 years ago.
There is no outstanding debt for APLT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
APLT Yearly Shares OutstandingAPLT Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
APLT Yearly Total Debt VS Total AssetsAPLT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

Based on the Altman-Z score of -35.07, we must say that APLT is in the distress zone and has some risk of bankruptcy.
APLT has a Altman-Z score of -35.07. This is amonst the worse of the industry: APLT underperforms 90.79% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -35.07
ROIC/WACCN/A
WACC8.8%
APLT Yearly LT Debt VS Equity VS FCFAPLT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M

2.3 Liquidity

A Current Ratio of 0.96 indicates that APLT may have some problems paying its short term obligations.
APLT has a Current ratio of 0.96. This is amonst the worse of the industry: APLT underperforms 88.53% of its industry peers.
APLT has a Quick Ratio of 0.96. This is a bad value and indicates that APLT is not financially healthy enough and could expect problems in meeting its short term obligations.
APLT has a worse Quick ratio (0.96) than 87.78% of its industry peers.
Industry RankSector Rank
Current Ratio 0.96
Quick Ratio 0.96
APLT Yearly Current Assets VS Current LiabilitesAPLT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 93.20% over the past year.
Looking at the last year, APLT shows a very negative growth in Revenue. The Revenue has decreased by -90.43% in the last year.
EPS 1Y (TTM)93.2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%72.92%
Revenue 1Y (TTM)-90.43%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%719.67%

3.2 Future

APLT is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.83% yearly.
APLT is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 206.95% yearly.
EPS Next Y31.47%
EPS Next 2Y21.8%
EPS Next 3Y17.28%
EPS Next 5Y13.83%
Revenue Next Year80.83%
Revenue Next 2Y73.6%
Revenue Next 3Y364.93%
Revenue Next 5Y206.95%

3.3 Evolution

APLT Yearly Revenue VS EstimatesAPLT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 100M 200M 300M 400M 500M
APLT Yearly EPS VS EstimatesAPLT Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 -1 -2 -3 -4

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for APLT. In the last year negative earnings were reported.
Also next year APLT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
APLT Price Earnings VS Forward Price EarningsAPLT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
APLT Per share dataAPLT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4 -0.6

4.3 Compensation for Growth

A more expensive valuation may be justified as APLT's earnings are expected to grow with 17.28% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y21.8%
EPS Next 3Y17.28%

More info and screens

0

5. Dividend

5.1 Amount

APLT does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

APPLIED THERAPEUTICS INC

NASDAQ:APLT (12/19/2025, 8:00:00 PM)

After market: 0.1262 +0 (+0.96%)

0.125

+0 (+1.13%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-13 2025-11-13/bmo
Earnings (Next)04-13 2026-04-13/amc
Inst Owners67.79%
Inst Owner Change4.32%
Ins Owners2.15%
Ins Owner Change2.34%
Market Cap18.04M
Revenue(TTM)1.00M
Net Income(TTM)-18.14M
Analysts80
Price Target1.7 (1260%)
Short Float %10.76%
Short Ratio1.06
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)9.92%
Min EPS beat(2)8.96%
Max EPS beat(2)10.87%
EPS beat(4)4
Avg EPS beat(4)81.18%
Min EPS beat(4)8.96%
Max EPS beat(4)282.27%
EPS beat(8)5
Avg EPS beat(8)-14.9%
EPS beat(12)7
Avg EPS beat(12)-10.44%
EPS beat(16)10
Avg EPS beat(16)-5.79%
Revenue beat(2)1
Avg Revenue beat(2)47.06%
Min Revenue beat(2)-100%
Max Revenue beat(2)194.12%
Revenue beat(4)1
Avg Revenue beat(4)-26.47%
Min Revenue beat(4)-100%
Max Revenue beat(4)194.12%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-42.03%
PT rev (3m)-42.03%
EPS NQ rev (1m)4.17%
EPS NQ rev (3m)19.3%
EPS NY rev (1m)6.11%
EPS NY rev (3m)6.11%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)200%
Revenue NY rev (3m)200%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 18.04
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.1
EYN/A
EPS(NY)-0.41
Fwd EYN/A
FCF(TTM)-0.6
FCFYN/A
OCF(TTM)-0.6
OCFYN/A
SpS0.01
BVpS0
TBVpS0
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -52.77%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-185.04%
ROA(5y)-152.5%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.96
Quick Ratio 0.96
Altman-Z -35.07
F-Score3
WACC8.8%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)93.2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%72.92%
EPS Next Y31.47%
EPS Next 2Y21.8%
EPS Next 3Y17.28%
EPS Next 5Y13.83%
Revenue 1Y (TTM)-90.43%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%719.67%
Revenue Next Year80.83%
Revenue Next 2Y73.6%
Revenue Next 3Y364.93%
Revenue Next 5Y206.95%
EBIT growth 1Y27.45%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year2.81%
EBIT Next 3Y26.24%
EBIT Next 5YN/A
FCF growth 1Y-60.35%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-60.35%
OCF growth 3YN/A
OCF growth 5YN/A

APPLIED THERAPEUTICS INC / APLT FAQ

What is the fundamental rating for APLT stock?

ChartMill assigns a fundamental rating of 1 / 10 to APLT.


What is the valuation status of APPLIED THERAPEUTICS INC (APLT) stock?

ChartMill assigns a valuation rating of 0 / 10 to APPLIED THERAPEUTICS INC (APLT). This can be considered as Overvalued.


How profitable is APPLIED THERAPEUTICS INC (APLT) stock?

APPLIED THERAPEUTICS INC (APLT) has a profitability rating of 0 / 10.


Can you provide the financial health for APLT stock?

The financial health rating of APPLIED THERAPEUTICS INC (APLT) is 0 / 10.